Setting new standards in information exchange for the pharmaceutical and biotech industry
Dpharm Europe Speaker Alexander Masters on Crowd Funding Cancer Cures
July 6, 2016
We are delighted to highlight the latest piece printed in the London Telegraph by DPharm Europe speaker, Alexander Masters on the latest in a new financial paradigm to help fight cancer.From the Telegraph:
The first person in the world to receive the only crowd-funded cancer drug in history will be Jan Smørlung, a village fire inspector, who doesn’t mind us pointing our camera lens at his groin. ‘Yes, thank you. I am happy to assist the world,’ he says.
A plump, healthy-looking man with a fresh haircut, wearing a white T-shirt, he looks like someone who rows out into misty forest lakes to catch a fish for breakfast. He has two children, six grandchildren and not much time.
For over a decade, Jan’s consultant, world famous clinician Kjell Öberg, has held back the inevitable with every treatment so far known to medicine, from chemotherapy to small radioactive balls dribbled into Jan’s blood.
Listen to Alexander’s Story on PharmaTalk Radio
Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer speaks with Alexander Masters, Author, Medical Campaigner and Co-Founder, iCancer.org.uk on:
- The story of the formation of iCancer.org.uk and the Oncolytic Virus Fund
- An alternative way to make clinical trials more accessible
- Ethical and moral issues
- A possible disruptive and sustainable model for other neglected medicines